Evidence map›Paper›PMID 34109009›Full record

ArticleNuclear medicine and molecular imaging2021

Angiogenesis-Targeted

Venkata Subramanian Krishnaraju, Rajender Kumar, Ashwani Sood, Jaya Shukla, Karthikeyan Subramanian, Nandita Kakkar, Naresh Panda, Bhagwant Rai Mittal

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Venkata Subramanian KrishnarajuDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.ORCID https://orcid.org/0000-0002-3929-2982
Rajender KumarDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Ashwani SoodDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.ORCID 0000-0001-7228-0361
Jaya ShuklaDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Karthikeyan SubramanianDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Nandita KakkarDepartment of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Naresh PandaDepartment of Otolaryngology (Head and Neck Surgery), Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Bhagwant Rai MittalDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondrosarcoma is a cartilaginous tumor of mesenchymal origin. The histology and grade of the tumor determine the chances of relapse and survival. These tumors usually respond poorly to chemo-radiotherapy in cases of non-resectable and recurrent disease.

Indexed as

AngiogenesisChondrosarcomaIntegrin αvβ3PET/CTRGD2Theranostics

Identifiers

PMID34109009
PMCPMC8140178
OpenAlexW3138212095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.